REFERENCES
- Coffee. Encyclopedia Britannica, Chicago, IL: Encyclopedia Britannica Inc, 2009.
- Baraldi PG, Tabriz A M, Gess S, Borea PA. Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility. Chem Rev 2008;108:238–263.
- Bodding M. Coffee has to be hot as hell, black as the devil, pure as an angel and sweet as love. Dtsch Med Wochenschr 2006;131:2889–2984.
- Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nut 2006;46:101–123.
- Tesfaye H, Biahos J, Janatová J. Coffee, its legend, history, and influence on human health. Cas Lek Cesk 2009;148:39–42.
- Lee TH. Good news for coffee addicts. Harv Bus Rev 2009;87:22,112.
- Nettleton JA, Follis JL, Schabath MB. Coffee intake, smoking and pulmonary function in the atherosclerosis risk in communities study. Am J Epidemiol 2009;169:1445–1453.
- Larsson SC, Bergkvist L, Giovannucci E, Wolk A. Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol 2006;163:638–644.
- Naganuma T, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Matsuda-Ohmori K, Shimazu T, Fukao A, Tsuji I. Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. Int J Cancer 2007;120:1542–1547.
- Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S, JPHC Study Group. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. Int J Cancer 2007;121:1312–1318.
- Nkondjock A. Coffee consumption and risk of cancer: an overview. Cancer Lett 2009;277:121–125.
- Tavani A, La Vecchia C. Coffee and cancer: a review of epidemiological studies, 1990–1999. Eur J Cancer Prev 2000;9:241–256.
- Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, Borea PA. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxemic human colon cancer cells. Mol Pharmacol 2007;72:395–406.
- Ritter M, Hohenberger K, Alter P, Herzum M, Tebbe J, Maisch M. Caffeine inhibits cytokine expression in lymphocytes. Cytokine 2005;30:177–181.
- Horrigan LA, Kellly JP, Connor TJ. Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther 2006;111;877–892.
- Sabisz M, Skladanowski A. Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more. Curr Pharm Biotechnol 2008;9:325–336.
- Ohta A, Gorelik E, Prasad SJ, Ronchese F, Lukashev D, Wong MK, Huang X, Caldwell S, Liu K, Smith P, Chen JF, Jackson EK, Apasov S, Abrams S, Sitkovsky M. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci USA 2006;103:13132–13137.
- Belizario JE, Tilly JL, Sherwood SW. Caffeine potentiates the lethality of tumor necrosis factor in cancer cells. Br J Cancer 1993;67:1229–1235.
- Tao KS, Wang W, Wang L, Cao DY, Li YQ, Wu SX, Dou KF. The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med Hypotheses 2008;71:730–736.
- Mandal A, Poddar MK. Long-term caffeine consumption reverses tumor- induced suppression on innate immune response in adult mice. Planta Med 2008;74:1779–1784.
- Heriot AG, Marriot JB, Cookson S, Kumar D, Dalgleish AG. Reduction in cytokine production in colorectal cancer patients: association with stage and reversal by resection. Br J Cancer 2000;82:1009–1012.
- Szkaradkiewicz A, Marciniak R, Chudzicka-Strugala I, Wasilewska A, Drews M, Majewski P, Karpiński T, Zwoździak B. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal patients. Arch Immunol Ther Exp (Warsz) 2009;57:291–294.
- Evans CF, Galustian C, Bodman-Smith M, Dalgleish A, Kumar D. The effect of colorectal cancer upon host peripheral immune cell function. Colorectal Dis 2009;12:561–569.